Quantitative structure-activity analyses of bufokinin and other tachykinins at bufokinin (bNK1) receptors of the small intestine of the cane toad, Bufo marinus

Biochemical Pharmacology

Volumn 69, Issue 2, 2005, Pages 329-338

  Liu, Lu ^a   Murray, Michael ^b   Conlon, J Michael ^c   Burcher, Elizabeth ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b University of Sydney   (Australia)

^c UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Amphibian; Binding; Bufokinin; Functional; Intestine; Non mammalian; QSAR; Structure activity; Substance P; Tachykinin receptors; Tachykinins

Indexed keywords

BUFOKININ; KININ; PHYSALAEMIN; RANATACHYKININ; SUBSTANCE P; TACHYKININ; TACHYKININ DERIVATIVE; TACHYKININ RECEPTOR; UNCLASSIFIED DRUG; NEUROKININ 1 RECEPTOR; SIGNAL PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MATHEMATICAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SMALL INTESTINE; STRUCTURE ACTIVITY RELATION; TOAD; AMINO ACID SUBSTITUTION; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG POTENTIATION; GENETICS; INTESTINE MUCOSA; METABOLISM; PHYSIOLOGY;

AMINO ACID SUBSTITUTION; ANIMALS; BUFO MARINUS; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTESTINAL MUCOSA; INTESTINE, SMALL; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RECEPTORS, NEUROKININ-1; TACHYKININS;

EID: 13844256868     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.09.023     Document Type: Article

References (28)

1. Holmgren S, Jensen J. Evolution of vertebrate neuropeptides. Brain Res Bull 2001;55:723-35.
2. Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, Maggi CA. Tachykinins and tachykinin receptors: a growing family. Life Sci 2004;74:1445-63. review.
3. Conlon JM. The tachykinin peptide family with particular emphasis on mammalian tachykinins and tachykinin receptor agonists. In: olzer P, editor. Handbook of experimental pharmacology, 64. Heidelberg: Springer-Verlag; 2004. p. 25-62.
4. Harrison S, Geppetti P, Substance P. Int J Biochem Cell Biol 2001;33:555-76.
5. Severini C, Salvadori S, Guerrini R, Falconieri-Erspamer G, Mignogna G, Erspamer V. Parallel bioassay of 39 tachykinins on 11 smooth muscle preparations. Structure and receptor selectivity/affinity relationship. Peptides 2000;21:1587-95.
6. Conlon JM, Warner FJ, Burcher E. Bufokinin: a substance P-related peptide from the gut of the toad, Bufo marinus with high affinity but low selectivity for mammalian tachykinin receptors. J Peptide Res 1998;51:210-5.
7. Liu L, Warner FJ, Conlon JM, Burcher E. Pharmacological and biochemical investigation of receptors for the toad gut tachykinin peptide, bufokinin, in its species of origin. Naunyn Schmiedebergs Arch Pharmacol 1999;360:187-95.
8. Liu L, Shang F, Perry MA, Comis A, Burcher E. Bufokinin: immunoreactivity, receptor localization and actions in intestine and mesenteric circulation of the toad. Peptides 2000;21:1345-54.
9. Liu L, Shang F, Comis A, Burcher E. Bufokinin: actions and distribution in the toad cardiovascular system. Clin Exp Pharmacol Physiol 2000;27:911-6.
10. Liu L, Markus I, Vandenberg RJ, Neilan BA, Murray M, Burcher E. Molecular identification and characterization of three isoforms of tachykinin NK1-like receptors in the cane toad, Bufo marinus. Am J Physiol Regul Integr Comp Physiol 2004;287:R575-85.
11. Liu L, Murray M, Burcher E. Structure-activity studies of bufokinin, substance P and their C-terminal fragments at bufokinin receptors in the small intestine of the cane toad, Bufo marinus. Biochem Pharmacol 2002;63:217-24.
12. Kier LB, Hall LL. Molecular connectivity in chemistry and drug design. New York: Academic Press; 1976.
13. Kier LB. Molecular connectivity as a descriptor of structure for SAR analyses. In: Yalkowsky SH, Sinkula AA, Valvani SC, editors. Physical chemical properties of drugs. New York: Marcel Dekker; 1980. p. 277-319.
14. Kier LB. Indexes of molecular shape from chemical graphs. Med Res Rev 1987;7:417-40.
15. Kier LB. A substituent steric effect index based on the molecular graph. Quant Struct Act Relat 1987;6:117-22.
16. Cramer III RD, Bunce JD, Patterson DE, Frank EI. Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quant Struct Act Relat 1988;7:18-25.
17. Kim KH. SD-quantitative structure-activity relationships: investigation of steric effects with descriptors directly from 3D structures using a comparative molecular field analysis (CoMFA) approach. Quant Struct Act Relat 1992;11:453-60.
18. Mansch C, Leo A, Unger SH, Kim KH, Nikaitani D, Lien EJ. Aromatic substituent constants for structure-activity correlations. J Med Chem 1973;16:1207-16.
19. Hansch C, Rockwell SD, Jow PYC, Leo A, Steller E. Substituent constants for correlation analysis. J Med Chem 1977;20:304-6.
20. Kier LB, Murray WJ, Hall LL. Molecular connectivity. 4. Relationship to biological activities. J Med Chem 1975;18:1272-4.
21. 8-SP) alters the conformation of the peptide in DMSO, water, and lipid bilayers. Biopolymers 1999;50:602-12.
22. Harbeson SL, Rovero P. Structure-activity relationships of agonist and antagonist ligands. In: Buck SH, editor. The tachykinin receptors. Totowa, New Jersey: Humana Press; 1994. p. 329-65.
23. Wang JX, Dipasquale AJ, Bray AM, Maeji NJ, Spellmeyer DC, Geysen HM. Systematic study of substance P analogs. II. Rapid screening of 512 substance P stereoisomers for binding to NK1 receptor. Int J Pept Protein Res 1993;42:392-9.
24. Falconieri-Erspamer G, Mazzanti G, Yasuhara T, Nakajima T. Parallel bioassay of physalaemin and hylambatin on smooth muscle preparations and blood pressure. J Pharm Pharmacol 1984;36:284-6.
25. Horwell DC, Howson W, Higginbottom M, Naylor D, Ratcliffe GS, Williams S. Quantitative structure-activity relationships (QSARs) of N-terminus fragments of NK1 tachykinin antagonists: a comparison of classical QSARs and three-dimensional QSARs from similarity matrices. J Med Chem 1995;38:4454-62.
26. Takeuchi Y, Shands EFB, Beusen DD, Marshall GR. Derivation of a three-dimensional pharmacaphore model of substance P antagonists bound to the neurokinin-1 receptor. J Med Chem 1998;41:3609-23.
27. Duffy RA. Potential therapeutic targets for neurokinin-1 receptor antagonists. Expert Opin Emerg Drugs 2004;9:9-21.
28. Gupta SP, Gupta JK, Nagappa AN, Jagannathan V, Gangwal D. QSAR study on renin inhibitors. Drug Des Deliv 1989;5:73-80.